Quote this publication Share Print

DYSPORT

-
Opinions on drugs - Posted on Apr 02 2013

Reason for request

Inclusion in a new indication: local symptomatic treatment of lower limb spasticity.

-


Clinical Benefit

Substantial

Substantial.


Clinical Added Value

no clinical added value

On the basis of available data, DYSPORT does not offer any improvement in actual benefit (no IAB, level V) compared with BOTOX in the local symptomatic treatment of lower limb spasticity in children aged 2 years and over.


Contact Us

Évaluation des médicaments

See also